Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,414 | 48,812 | 40,285 | 24,459 | 29,866 |
| Marketable Securities | 16,937 | 15,545 | 18,377 | 33,747 | 51,776 |
| Receivables | 23,546 | 20,819 | 29,366 | 40,320 | 15,525 |
| Inventories | 6,112 | 10,782 | 11,077 | 9,118 | 7,116 |
| TOTAL | $95,024 | $100,925 | $106,972 | $115,903 | $110,440 |
| Non-Current Assets | |||||
| PPE Net | 190 | 215 | 294 | 857 | 1,694 |
| Intangibles | 14,146 | 14,413 | 14,681 | 14,949 | 0 |
| Other Non-Current Assets | 5,964 | 1,538 | 1,665 | 2,570 | 3,475 |
| TOTAL | $20,300 | $16,166 | $16,640 | $18,376 | $5,169 |
| Total Assets | $115,324 | $117,091 | $123,612 | $134,279 | $115,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,999 | 5,240 | 6,295 | 22,508 | 2,721 |
| Accrued Expenses | 13,847 | 12,565 | 12,601 | 16,574 | 16,347 |
| Other current liabilities | 19,369 | 19,384 | 19,708 | 17,142 | 5,912 |
| TOTAL | $48,273 | $44,023 | $45,518 | $65,211 | $47,265 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,659 | 59,574 | 59,484 | 39,448 | 39,468 |
| Deferred Revenues | 1,355 | 1,355 | 1,369 | 1,369 | 1,369 |
| Other Non-Current Liabilities | 39,226 | 41,609 | 42,867 | 43,236 | 48,710 |
| TOTAL | $98,885 | $101,183 | $102,351 | $82,684 | $88,178 |
| Total Liabilities | $147,158 | $145,206 | $147,869 | $147,895 | $135,443 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,437 | 17,436 | 17,367 | 17,365 | 17,284 |
| Common Shares | 175 | 175 | 174 | 174 | 173 |
| Retained earnings | -1,408,287 | -1,402,595 | -1,395,995 | -1,382,459 | -1,383,860 |
| Other shareholders' equity | -15 | -25 | -27 | -153 | -286 |
| TOTAL | $-31,834 | $-28,115 | $-24,257 | $-13,616 | $-19,834 |
| Total Liabilities And Equity | $115,324 | $117,091 | $123,612 | $134,279 | $115,609 |